{"status":true,"post":{"id":41250,"user_id":24,"status":1,"type":1,"orde":null,"notification_type":3,"static_post":0,"published_at":"2023-07-03 08:39:00","created_at":"2023-07-03T05:39:00.000000Z","updated_at":"2023-07-03T05:39:00.000000Z","edited_at":"2024-12-17 22:35:21","source_id":null,"post_id":41250,"is_featured":0,"title":"Kanser ara\u015ft\u0131rmalar\u0131 i\u00e7in TRANSCAN-3 \u00e7a\u011fr\u0131s\u0131 a\u00e7\u0131ld\u0131","slider_title":null,"slider_title_2":null,"slider_spot_title":null,"slider_spot_title_2":null,"home_title":null,"sub_title":null,"category_id":73,"description":"AHMET KARATA\u015e","content":"

<\/span><\/strong>
<\/span><\/strong><\/p>

ahmetkaratas1453@gmail.com<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

ERA-NET Cofund projelerinden biri de ulusal ve b\u00f6lgesel translasyonel kanser ara\u015ft\u0131rmalar\u0131n\u0131 destekleyen fonlama kurulu\u015flar\u0131n\u0131 bir araya getiren TRANSCAN-3\u2019t\u00fcr.<\/span><\/p>

\u00a0<\/span><\/p>

\u00c7a\u011fr\u0131larda, Avrupa Birli\u011fi \u00c7er\u00e7eve Programlar\u0131 ve benzeri uluslararas\u0131 kat\u0131l\u0131m\u0131 destekleyici ikili ve \u00e7ok tarafl\u0131 mekanizmalar ile uyumlu bir \u015fekilde \u00fcniversite-sanayi-kamu i\u015fbirlikleri \u00f6zendiriliyor.<\/span><\/p>

\u00a0<\/span><\/p>

\u00c7A\u011eRI KONUSU<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

\u00c7a\u011fr\u0131n\u0131n hedefi, kanser epigeneti\u011finin daha iyi anla\u015f\u0131lmas\u0131na dayal\u0131 yeni yakla\u015f\u0131mlar\u0131n geli\u015ftirilmesi yoluyla kanserlerin tespiti, te\u015fhisi, prognozu ve tedavisinin etkinli\u011fini art\u0131rmakt\u0131r.<\/span><\/p>

\u00a0<\/span><\/p>

TRANSCAN-3 projesi 2023 y\u0131l\u0131 Uluslararas\u0131 Ortak \u00c7a\u011fr\u0131s\u0131 (JTC2023), \u2018Kanser Epigeneti\u011fi \u00dczerine Translasyonel Ara\u015ft\u0131rmalar\u2019 olarak belirlenmi\u015ftir.<\/span><\/p>

\u00a0<\/span><\/p>

Sunulacak projeler \u015fu hedeflerden en az birini kapsamal\u0131:<\/span><\/p>

\u00a0<\/span><\/p>

* Epigeneti\u011fin kanserin ba\u015flamas\u0131 ve ilerlemesindeki rol\u00fc. Bu \u00e7al\u0131\u015fmalar, kanserlerin tespitini, tan\u0131s\u0131n\u0131, prognozunu veya tedavilere yan\u0131t\u0131 iyile\u015ftirmek i\u00e7in yeni biyobelirte\u00e7leri do\u011frulamay\u0131 ama\u00e7layabilir.<\/span><\/p>

\u00a0<\/span><\/p>

* Kanserin ilerlemesini s\u0131n\u0131rlamak, relaps\u0131\/n\u00fcksetmeyi \u00f6nlemek, mevcut kanser \u00f6nleyici tedavilerin etkinli\u011fini art\u0131rmak veya toksisitesini azaltmak i\u00e7in yeni epigenetik tabanl\u0131 terap\u00f6tik stratejilerin do\u011frulanmas\u0131.<\/span><\/p>

\u00a0<\/span><\/p>

\u00c7a\u011fr\u0131 kurallar\u0131, proje gereksinimleri ve projelerden beklenen di\u011fer niteliklere ili\u015fkin detayl\u0131 bilgilere uluslararas\u0131 \u00e7a\u011fr\u0131 sayfas\u0131ndan ula\u015f\u0131labilir.<\/span><\/p>

\u00a0<\/span><\/p>

Projeler hangi kapsamda de\u011ferlendirilecek?<\/span><\/strong><\/p>

\u00a0<\/span><\/strong><\/p>

T\u00fcrkiye\u2019de yerle\u015fik kurulu\u015flar ve ara\u015ft\u0131rmac\u0131lar, T\u00dcB\u0130TAK-1071 Uluslararas\u0131 Ara\u015ft\u0131rma Fonlar\u0131ndan Yararlanma Kapasitesinin ve Uluslararas\u0131 Ar-Ge \u0130\u015fbirliklerine Kat\u0131l\u0131m\u0131n Art\u0131r\u0131lmas\u0131na Y\u00f6nelik Destek Program\u0131 kapsam\u0131nda desteklenecek.<\/span><\/p>

\u00a0<\/span><\/p>

DESTEK ORANI<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

* \u00dcniversiteler\/kamu kurum ve kurulu\u015flar\u0131: Y\u00fczde 100,<\/span><\/p>

\u00a0<\/span><\/p>

* B\u00fcy\u00fck firmalar: Y\u00fczde 60,<\/span><\/p>

\u00a0<\/span><\/p>

* KOB\u0130\u2019ler: Y\u00fczde 75 destek oran\u0131 ile destekleniyor.<\/span><\/p>

\u00a0<\/span><\/p>

PROJE NASIL SUNULACAK?<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

Proje \u00f6nerileri i\u00e7in olu\u015fturulan konsorsiyumun en az 3 farkl\u0131 TRANSCAN-3 payda\u015f\u0131 \u00fclkeden minimum 3, maksimum 6 proje partneri (koordinat\u00f6r dahil) i\u00e7ermesi gerekiyor. Projede Macaristan, Letonya, Slovakya veya T\u00fcrkiye\u2019den partner yer al\u0131yorsa maksimum partner say\u0131s\u0131 7\u2019ye \u00e7\u0131kar\u0131labilir.<\/span><\/p>

\u00a0<\/span><\/p>

Uluslararas\u0131 konsorsiyumun birinci a\u015fama \u0130ngilizce proje ba\u015fvurusunun, Uluslararas\u0131 Ortak \u00c7a\u011fr\u0131 Sekretaryas\u0131\u2019na (JCS) online sistem \u00fczerinden yap\u0131lmas\u0131 gerekiyor. https:\/\/ptoutline.eu\/app\/transcan2023\u00a0<\/span><\/p>

\u00a0<\/span><\/p>

Uluslararas\u0131 ba\u015fvurunun yan\u0131 s\u0131ra projede yer alan T\u00fcrk kurum\/kurulu\u015flar taraf\u0131ndan ayr\u0131ca T\u00dcB\u0130TAK\u2019a, PBS (https:\/\/uidb-pbs.tubitak.gov.tr\/) \u00fczerinden 1. a\u015fama ulusal ba\u015fvurunun elektronik imzal\u0131 olarak yap\u0131lmas\u0131 gerekiyor.<\/span><\/p>

\u00a0<\/span><\/p>

SON BA\u015eVURU TAR\u0130H\u0130<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

\u0130ki a\u015famal\u0131 ba\u015fvuru al\u0131nacak olan TRANSCAN-3 2023 y\u0131l\u0131 \u00e7a\u011fr\u0131s\u0131n\u0131n uluslararas\u0131 1. a\u015fama son ba\u015fvuru tarihi: 21 Temmuz 2023\u00a0<\/span><\/p>

\u00a0<\/span><\/p>

Bilgi i\u00e7in:<\/span><\/em><\/strong><\/p>

\u00d6zge G\u00f6zay \u00d6zdede<\/span><\/em><\/strong><\/p>

U\u0130DB AB \u00c7er\u00e7eve Programlar\u0131 M\u00fcd\u00fcrl\u00fc\u011f\u00fc<\/span><\/em><\/strong><\/p>

ozge.gozay@tubitak.gov.tr<\/span><\/em><\/strong><\/p>","slug":"kanser-arastirmalari-icin-transcan-3-cagrisi-acildi","tags":null,"meta_title":null,"meta_description":null,"meta_keywords":null,"news_cover_min":"\/front\/uploads\/blog\/thumbnail\/1688331600duUgHyXUC19rZWt.webp","news_cover":null,"news_video_min":null,"news_video":null,"view_count":1882,"cropped_1200x675":null,"user":{"id":24,"name":"AHMET","surname":"KARATA\u015e","email":"ahmet-karatas@gmail.com","slug":"ahmet-karatas","avatar":"\/front\/uploads\/avatar\/1733691600RvOc8asYeymJ5xF.webp","status":1,"role":1,"email_verified_at":null,"orde":null,"created_at":"2022-10-19T14:42:06.000000Z","updated_at":"2025-01-30T12:33:20.000000Z","seo_title":null,"seo_description":null},"translations":[{"id":41376,"is_featured":0,"is_amp":0,"is_ads":0,"ads_link":null,"post_id":41250,"locale":"tr","category_id":73,"title":"Kanser ara\u015ft\u0131rmalar\u0131 i\u00e7in TRANSCAN-3 \u00e7a\u011fr\u0131s\u0131 a\u00e7\u0131ld\u0131","home_title":null,"sub_title":null,"slider_title":null,"slider_title_2":null,"slider_spot_title":null,"slider_spot_title_2":null,"subtitleuse":0,"description":"AHMET KARATA\u015e","content":"

<\/span><\/strong>
<\/span><\/strong><\/p>

ahmetkaratas1453@gmail.com<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

ERA-NET Cofund projelerinden biri de ulusal ve b\u00f6lgesel translasyonel kanser ara\u015ft\u0131rmalar\u0131n\u0131 destekleyen fonlama kurulu\u015flar\u0131n\u0131 bir araya getiren TRANSCAN-3\u2019t\u00fcr.<\/span><\/p>

\u00a0<\/span><\/p>

\u00c7a\u011fr\u0131larda, Avrupa Birli\u011fi \u00c7er\u00e7eve Programlar\u0131 ve benzeri uluslararas\u0131 kat\u0131l\u0131m\u0131 destekleyici ikili ve \u00e7ok tarafl\u0131 mekanizmalar ile uyumlu bir \u015fekilde \u00fcniversite-sanayi-kamu i\u015fbirlikleri \u00f6zendiriliyor.<\/span><\/p>

\u00a0<\/span><\/p>

\u00c7A\u011eRI KONUSU<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

\u00c7a\u011fr\u0131n\u0131n hedefi, kanser epigeneti\u011finin daha iyi anla\u015f\u0131lmas\u0131na dayal\u0131 yeni yakla\u015f\u0131mlar\u0131n geli\u015ftirilmesi yoluyla kanserlerin tespiti, te\u015fhisi, prognozu ve tedavisinin etkinli\u011fini art\u0131rmakt\u0131r.<\/span><\/p>

\u00a0<\/span><\/p>

TRANSCAN-3 projesi 2023 y\u0131l\u0131 Uluslararas\u0131 Ortak \u00c7a\u011fr\u0131s\u0131 (JTC2023), \u2018Kanser Epigeneti\u011fi \u00dczerine Translasyonel Ara\u015ft\u0131rmalar\u2019 olarak belirlenmi\u015ftir.<\/span><\/p>

\u00a0<\/span><\/p>

Sunulacak projeler \u015fu hedeflerden en az birini kapsamal\u0131:<\/span><\/p>

\u00a0<\/span><\/p>

* Epigeneti\u011fin kanserin ba\u015flamas\u0131 ve ilerlemesindeki rol\u00fc. Bu \u00e7al\u0131\u015fmalar, kanserlerin tespitini, tan\u0131s\u0131n\u0131, prognozunu veya tedavilere yan\u0131t\u0131 iyile\u015ftirmek i\u00e7in yeni biyobelirte\u00e7leri do\u011frulamay\u0131 ama\u00e7layabilir.<\/span><\/p>

\u00a0<\/span><\/p>

* Kanserin ilerlemesini s\u0131n\u0131rlamak, relaps\u0131\/n\u00fcksetmeyi \u00f6nlemek, mevcut kanser \u00f6nleyici tedavilerin etkinli\u011fini art\u0131rmak veya toksisitesini azaltmak i\u00e7in yeni epigenetik tabanl\u0131 terap\u00f6tik stratejilerin do\u011frulanmas\u0131.<\/span><\/p>

\u00a0<\/span><\/p>

\u00c7a\u011fr\u0131 kurallar\u0131, proje gereksinimleri ve projelerden beklenen di\u011fer niteliklere ili\u015fkin detayl\u0131 bilgilere uluslararas\u0131 \u00e7a\u011fr\u0131 sayfas\u0131ndan ula\u015f\u0131labilir.<\/span><\/p>

\u00a0<\/span><\/p>

Projeler hangi kapsamda de\u011ferlendirilecek?<\/span><\/strong><\/p>

\u00a0<\/span><\/strong><\/p>

T\u00fcrkiye\u2019de yerle\u015fik kurulu\u015flar ve ara\u015ft\u0131rmac\u0131lar, T\u00dcB\u0130TAK-1071 Uluslararas\u0131 Ara\u015ft\u0131rma Fonlar\u0131ndan Yararlanma Kapasitesinin ve Uluslararas\u0131 Ar-Ge \u0130\u015fbirliklerine Kat\u0131l\u0131m\u0131n Art\u0131r\u0131lmas\u0131na Y\u00f6nelik Destek Program\u0131 kapsam\u0131nda desteklenecek.<\/span><\/p>

\u00a0<\/span><\/p>

DESTEK ORANI<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

* \u00dcniversiteler\/kamu kurum ve kurulu\u015flar\u0131: Y\u00fczde 100,<\/span><\/p>

\u00a0<\/span><\/p>

* B\u00fcy\u00fck firmalar: Y\u00fczde 60,<\/span><\/p>

\u00a0<\/span><\/p>

* KOB\u0130\u2019ler: Y\u00fczde 75 destek oran\u0131 ile destekleniyor.<\/span><\/p>

\u00a0<\/span><\/p>

PROJE NASIL SUNULACAK?<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

Proje \u00f6nerileri i\u00e7in olu\u015fturulan konsorsiyumun en az 3 farkl\u0131 TRANSCAN-3 payda\u015f\u0131 \u00fclkeden minimum 3, maksimum 6 proje partneri (koordinat\u00f6r dahil) i\u00e7ermesi gerekiyor. Projede Macaristan, Letonya, Slovakya veya T\u00fcrkiye\u2019den partner yer al\u0131yorsa maksimum partner say\u0131s\u0131 7\u2019ye \u00e7\u0131kar\u0131labilir.<\/span><\/p>

\u00a0<\/span><\/p>

Uluslararas\u0131 konsorsiyumun birinci a\u015fama \u0130ngilizce proje ba\u015fvurusunun, Uluslararas\u0131 Ortak \u00c7a\u011fr\u0131 Sekretaryas\u0131\u2019na (JCS) online sistem \u00fczerinden yap\u0131lmas\u0131 gerekiyor. https:\/\/ptoutline.eu\/app\/transcan2023\u00a0<\/span><\/p>

\u00a0<\/span><\/p>

Uluslararas\u0131 ba\u015fvurunun yan\u0131 s\u0131ra projede yer alan T\u00fcrk kurum\/kurulu\u015flar taraf\u0131ndan ayr\u0131ca T\u00dcB\u0130TAK\u2019a, PBS (https:\/\/uidb-pbs.tubitak.gov.tr\/) \u00fczerinden 1. a\u015fama ulusal ba\u015fvurunun elektronik imzal\u0131 olarak yap\u0131lmas\u0131 gerekiyor.<\/span><\/p>

\u00a0<\/span><\/p>

SON BA\u015eVURU TAR\u0130H\u0130<\/span><\/strong><\/p>

\u00a0<\/span><\/p>

\u0130ki a\u015famal\u0131 ba\u015fvuru al\u0131nacak olan TRANSCAN-3 2023 y\u0131l\u0131 \u00e7a\u011fr\u0131s\u0131n\u0131n uluslararas\u0131 1. a\u015fama son ba\u015fvuru tarihi: 21 Temmuz 2023\u00a0<\/span><\/p>

\u00a0<\/span><\/p>

Bilgi i\u00e7in:<\/span><\/em><\/strong><\/p>

\u00d6zge G\u00f6zay \u00d6zdede<\/span><\/em><\/strong><\/p>

U\u0130DB AB \u00c7er\u00e7eve Programlar\u0131 M\u00fcd\u00fcrl\u00fc\u011f\u00fc<\/span><\/em><\/strong><\/p>

ozge.gozay@tubitak.gov.tr<\/span><\/em><\/strong><\/p>","slug":"kanser-arastirmalari-icin-transcan-3-cagrisi-acildi","orjinalimage":"\/front\/uploads\/blog\/thumbnail\/1688331600duUgHyXUC19rZWt.webp","news_cover_min":"\/front\/uploads\/blog\/thumbnail\/1688331600duUgHyXUC19rZWt.webp","news_cover":null,"news_video_min":null,"news_video":null,"cropped_638x552":null,"cropped_310x208":null,"cropped_416x247":null,"cropped_197x247":null,"cropped_416x600":null,"cropped_1200x675":null,"tags":null,"meta_title":null,"meta_description":null,"meta_keywords":null,"view_count":1882,"yt":0,"ytid":"","ytimage":null,"imgdate":"2000-01-01 00:00:00","cuff_cover":null,"cropped_358x214":null,"cropped_842x474":null}]}}